Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Aspirin Stories

2012-02-28 15:05:00

NASHVILLE, Tenn., Feb. 28, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced it has entered into an exclusive agreement with China's Harbin Gloria Pharmaceuticals Co., Ltd. (SHE: 002437)for the commercialization of Acetadote® (acetylcysteine), its injectable drug used to treat acetaminophen overdose, and Caldolor® (ibuprofen) Injection, which is used to treat pain and fever in the hospital setting. The agreement will provide Harbin Gloria...

2012-02-14 14:09:35

Scientists at Emory University School of Medicine have identified a new group of compounds that may protect brain cells from inflammation linked to seizures and neurodegenerative diseases. The compounds block signals from EP2, one of the four receptors for prostaglandin E2, which is a hormone involved in processes such as fever, childbirth, digestion and blood pressure regulation. Chemicals that could selectively block EP2 were not previously available. In animals, the EP2 blockers could...

2012-02-07 23:25:48

Anticoagulation therapies may be necessary to prevent blood clots in high-risk patients Following a total joint replacement, anticoagulation (blood thinning) drugs can prevent Deep Vein Thrombosis (DVT), a blood clot deep within the extremities, or a pulmonary embolism (PE), a complication that causes a blood clot to move to the lungs. However, prolonged use of these therapies may increase the risk of hemorrhage and infection. In the study, "Aspirin was Effective to Prevent Proximal DVT...

2012-02-03 19:00:25

In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were similar in preventing deaths and strokes in heart failure patients with normal heart rhythm, according to late-breaking research presented at the American Stroke Association´s International Stroke Conference 2012. “Although there was a warfarin benefit for patients treated for four or more years, overall, warfarin and aspirin were similar,” said Shunichi Homma,...

2012-02-03 19:00:11

The anti-blood clot regimen that adds the drug clopidogrel (Plavix) to aspirin treatment is unlikely to prevent recurrent strokes and may increase the risk of bleeding and death in patients with subcortical stroke according to late-breaking research presented at the American Stroke Association´s International Stroke Conference 2012. Because of these preliminary results, researchers ended the anti-clotting part of the Secondary Prevention of Small Subcortical Strokes Trial (SPS3) in...

2012-02-03 09:42:00

RIDGEFIELD, Conn., Feb. 3, 2012 /PRNewswire/ -- Boehringer Ingelheim presented results of a drug interaction study that found Aggrenox® (aspirin/extended-release dipyridamole), an antiplatelet medication, is not affected by the co-administration of omeprazole, a proton pump inhibitor (PPI), frequently used to treat several gastrointestinal conditions. These data were presented at the International Stroke Conference (ISC) in New Orleans. "Omeprazole has been shown to interact with some...

2012-02-01 08:05:00

MORRISTOWN, N.J., Feb. 1, 2012 /PRNewswire/ -- February is American Heart Month and a time when television personality Joy Behar, and her daughter Eve, reflect on their family history of heart disease and recommit to living a heart-healthy life. That's why they are teaming up with the makers of Bayer® Aspirin and WomenHeart: The National Coalition for Women with Heart Disease, to raise $100,000 for the fight against heart disease. (Logo:...

2012-01-18 10:47:05

New findings from a research study led by physicians at Scripps Health reveal that the drug cangrelor has the unique properties of achieving very fast blood thinning effects when needed to protect from heart attacks, but also dissipates rapidly so patients can undergo surgery without the excessive bleeding often associated with blood thinning medications. Initial results from the BRIDGE trial will be published Jan. 18, 2012, in an article in the Journal of the American Medical Association...

2012-01-08 11:12:00

PARSIPPANY, N.J., Jan. 8, 2012 /PRNewswire/ -- Novartis Consumer Health, Inc. (NCH) announced today that it is voluntarily recalling all lots of select bottle packaging configurations of Excedrin(®) and NoDoz(® )products with expiry dates of December 20, 2014 or earlier as well as Bufferin(®) and Gas-X Prevention(®) products with expiry dates of December 20, 2013 or earlier, in the United States. NCH is taking this action as a precautionary measure because the...

2011-12-13 19:19:36

Many a stumped adult searching for the perfect gift to give a loved one this holiday season is finding help from the national Million Hearts initiative.  Whether someone is pinching pennies or the sky is the limit, good health is the one thing everyone appreciates. In a little twist on the online postcards called e-cards, the national Million Hearts initiative is asking gift givers to consider taking care of their own health as a gift to a loved one. “Family members worry about...